Option chain shows key data for Lipocine's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Lipocine.

Lipocine (NASDAQ:LPCN) Stock, Option Chain

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ABVC

ALGN

ASPS

ASXC

BHVN

CLBK

CROX

CTCX

EBAY

ENVX

EOLS

FEMY

FFWM

IMAX

INPX

INSG

KLAC

LIXT

LPCN

LRCX

MRSN

NOVA

NVCR

OSTK

OTLY

PRFT

SHYF

SIMO

TNET

TPIC

TREE

TTNP

ULBI

VIEW

WRNT

YELL

Gainers


	Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.


Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Biotech

Health Care

General

Lipocine Inc (NASDAQ: LPCN) shares are trading higher after the company released topline results from a Phase 2 clinical study of LPCN 1148, an oral candidate under development for the 

Why Lipocine Stock Is Moving Higher Today?

ABST

ACVA

ADSE

AMPE

BBIG

BBLN

BFLY

BNMV

BPTS

BYND

CDRO

CLSK

CPRX

DADA

DYNT

ENTG

GFAI

GRIL

GRPN

IBRX

IMBI

INTZ

JAGX

KLXE

MANU

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MGNI

MINM

MTNB

MXCT

NEPT

ORGO

PACW

PHAR

POLA

PRPL

SBFM

SMRT

SONO

TIVC

VATE

VCIG

VYNT

ZURA

Gainers


	Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 109.8% to $1.06 after reporting a rise in Q1 sales.


Why Groupon Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Lipocine Inc

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Athira Pharma

CalciMedica

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cingulate

Cocrystal Pharma

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals

Dare Bioscience

Durect

Gelteq

Hoth Therapeutics

IGC Pharma

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lexaria Bioscience

Lipocine

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

ProPhase Labs

Pulmatrix

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Scilex Holding

Talphera

Traws Pharma

TherapeuticsMD

VYNE Therapeutics

Comments

Lipocine

Lipocine (LPCN) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell